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Abstract
Changes in the hypothalamic-pituitary-adrenal (HPA) axis activity constitute a key compo-
nent of bipolar mania, but the extent and nature of these alterations are not fully understood.
We use here the lateral hypothalamic-kindled (LHK) rat model to deliberately induce an
acute manic-like episode and measure serum corticosterone concentrations to assess
changes in HPA axis activity. A mathematical model is developed to succinctly describe the
entwined biochemical transformations that underlay the HPA axis and emulate by numerical
simulations the considerable increase in serum corticosterone concentration induced by
LHK. Synergistic combination of the LHK rat model and dynamical systems theory allows us
to quantitatively characterize changes in HPA axis activity under controlled induction of
acute manic-like states and provides a framework to study in silico how the dynamic integra-
tion of neurochemical transformations underlying the HPA axis is disrupted in these states.
Introduction
Bipolar disorder type I (BPI) is a serious medical condition characterized by mania alone or
mania alternating with depression. As many as 1% of the general population are estimated to
suffer from BPI at some point during their lifetime [1]. The high medical comorbidity [2], sui-
cide rate [3] and economic burden [4] of BPI is accentuated by marginally effective pharmaco-
logical therapies [5]. Understanding the neurobiological basis of mania is necessary to develop
valid biological markers and create novel therapeutics for bipolar disorder.
Accumulating evidence over the past five decades documents dysregulation of the hypotha-
lamic-pituitary-adrenal (HPA) axis during mania [reviewed recently [6–8]]. However the
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results of this rich literature remain conflicting. Numerous studies show clear hyperactivity of
the HPA axis in manic or BP patients as evident by increased evening cortisol concentrations
during mania in plasma [9–15], saliva [16,17] and cerebrospinal fluid (CSF) [18–20]; and high
hair cortisol concentrations in BP patients with an illness onset 30 [21]. More evidence is
obtained from studies employing the dexamethasone suppression test (DexST) or the dexa-
methasone/corticotrophin releasing hormone (Dex/CRH) suppression test to probe the HPA
axis. Bipolar manic patients show non-suppression in many well designed studies [9,18,19,22–
34]. Along the same lines of HPA axis hyperactivity, recent data showed reduced glucocorti-
coid receptor responsiveness [35], and increased activity of cortisol metabolizing enzymes 5β
reductase and 11β-hydroxysteroid dehydrogenase and a trend towards increased activity for
the 5ɑ reductase [36] in bipolar patients. Other studies, however, showed no HPA axis hyper-
activity during mania as evident by normal concentrations of urinary tetrahydrocortisol [37],
or even lower urinary free cortisol during manic episodes in a rapid cycling patient [38] or
lower urinary 17-ketosteroid levels during mania [39–41]. Similar negative findings showed
no differences between manic and healthy controls in plasma hydrocortisone [42], plasma
11-hydroxy corticosteroid [43], or plasma cortisol [10,43–46], and even significantly lower
plasma cortisol concentrations during manic episodes in two rapid cycling bipolar patients
[47]. In addition, measurements of CSF cortisol concentrations between manic and control
probands with neurological disorders [48], or controls with severe axis II disorders [49], or
healthy controls [50] did not reveal any significant differences. Moreover, normal cortisol sup-
pressions in the DexST were repeatedly observed in manic patients [51–54] and no difference
in cortisol levels following Dex/CRH suppression test during manic episodes and during
remission was reported in 5 rapid cycling BP patients [55].
These apparently conflicting findings could, to some extent, be attributed to methodologi-
cal variables such as the timing of sample collection. For example, in Schlesser’s cohort of 61
manic patients where all patients were found to have normal cortisol suppression in the
DexST, the plasma cortisol concentration was measured in the morning [51]. In contrast, in
studies showing non-suppression cortisol was measured in the evening [23,26]. Also the vari-
ability in mania phenotype can lead to conflicting results–for instance, several studies showed
HPA hyperactivity is more frequently seen in mixed than pure mania [6,19,20,24,25,52]. Sex
differences in the HPA axis in general [56,57] and in manic patients specifically [58] could also
contribute to the variability in the results. Another equally important variable stems from the
profound complexity of the HPA axis dynamics, with different patterns of hormonal oscilla-
tions that require sophisticated ways of data analysis [59].
The aim of this study is twofold: (1) to characterize changes in the HPA axis dynamics dur-
ing mania-like state induction in the LHK rat model by measuring changes in serum cortico-
sterone levels; and (2) to develop a mathematical model that can emulate these changes.
The LHK rat model is a recently developed animal model where manic-like behavior is induced
under controlled conditions by repeatedly stimulating the lateral hypothalamic area with electrical
pulses of gradually increasing intensities [60,61]. LHK induces multifaceted manifestations, such
as sexual self-stimulation, excessive rearing, feeding and grooming behaviors, and increased total
locomotor activity. In this respect, the LHK rat model is more closely reminiscent of human manic
episode than the amphetamine-injected rodent model [62] or the Clock mutant mouse model
[63], which do not reflect to the same extent the multifaceted symptomatology of mania, and
where locomotor activity remains the primary measure of altered behavior.
Mathematical modeling of HPA axis dynamics is a powerful tool to describe the dynamic
integration of the nervous and the endocrine systems’ functions, investigate self-regulation of
the neuroendocrine system and the effect of internal and external stressors on its activity [64–
71]. We have recently developed a five-dimensional reaction model of human HPA axis, with
HPA axis dynamics in LHK rat
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concentrations of corticotrophin releasing hormone ([CRH]), adrenocorticotrophic hormone
([ACTH]), cortisol ([CORT]), aldosterone ([ALDO]) and cholesterol ([CHOL]) as dynamic
variables [69,70]. This core model was systematically fine-tuned by Stoichiometric Network
Analysis (SNA), a general flux balance analysis method for optimization of reaction networks
and determination of instability regions [72–75]. Based on this work, an extended model was
developed to describe ethanol effects on the HPA axis [71]. These models were used here as a
basis for the development of a rodent model of HPA axis, as described in the Material and
Methods section. Mathematical modeling and dynamical systems theory enable us to investi-
gate in silico how the underlying biochemical pathways are intertwined to give an integral
HPA axis response at the organism level and examine theoretically how dynamic properties of
the HPA axis change when the rates of individual pathways change, thereby helping us to
understand how HPA axis activity is changed at the organism level in acute or chronic manic
states.
Materials and methods
Animals and ethics
Experimental protocols were reviewed and approved by the Mayo Clinic Institutional Animal
Care and Use Committee and the methods were carried out in accordance with the approved
guidelines. Male Wister rats, 250–300 g (Charles Rivers, International, Inc. Wilmington, MA)
were housed in individual cages with ordinary bedding under 12 hour light/12 hour dark cycle
with lights on at 6:00 AM, temperature was kept around 21˚C, and humidity between 40–70%
with free access to standard rodent chow and water. Three experimental groups were used:
control group (no electrodes implanted in the lateral hypothalamus; n = 6), sham group (elec-
trodes implanted in the lateral hypothalamus but not kindled; n = 7), and kindled group (elec-
trodes implanted in the lateral hypothalamus and kindled; n = 7). During the experimental
procedure, ten animals were excluded due to difficult access or blocked jugular vein catheter
(n = 4), pulling stimulating electrode and/or jugular vein catheter during mania induction
(n = 5) or dying during blood sampling (n = 1) among twenty animals used in this experiment.
Sampling was successfully achieved in 3–4 animals/group. The experiments were conducted in
three series, totally lasting over three months. In each series, two animals from the control
group were analyzed during two consecutive days; followed by analysis of two animals from
the sham group and two animals from the LHK group. Thereafter, a new series of experiments
was initiated.
External jugular vein cannulation surgery
Anesthetized animals (isoflurane inhalation: 3.0% during induction and 1%-1.5% during
maintenance) were placed on the surgery table and a 2 cm × 4 cm area was shaved on the ven-
tral aspect of the neck, and another 1 cm × 1 cm area was shaved on the upper back of the ani-
mal between the two scapulae to externalize the catheter. A 1.5 cm longitudinal skin incision
was made ventrally along the midline of the neck. The right external jugular vein was separated
from the surrounding tissues. A 5.0 F silastic silicon catheter (#62999–133, inner/outer diame-
ters 0.76/1.65 mm, VWR, IL, USA) filled with heparinized saline (1 unit in 0.1 ml) was inserted
into the vein, then secured in place and tunneled under the skin through a subcutaneously
implanted skin button with Dacron patch and silicon sleeve (#SBD-02; SAI-Infusion Technol-
ogies, IL, USA) to prevent the catheter from slipping during the mania-induction experiments.
The catheter was then externalized through the upper back incision and flushed immediately
with heparinized saline then sealed with a stainless steel plug. The skin incisions were then
sutured with 4/0 silk sutures [76].
HPA axis dynamics in LHK rat
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Surgical implantation of stimulating electrodes
Anesthetized animals (isoflurane inhalation: 3.0% during induction and 1%-1.5% during
maintenance) were secured in the stereotaxic apparatus (David Kopf Instruments, Tujunga,
CA) and the skull levelled between bregma and lambda. Bipolar stimulating electrodes
(#MS303 twisted stainless steel, outer diameter 125 μm, Plastics One, Inc., Roanoke, VA. USA)
were implanted bilaterally into the lateral hypothalamic area (A/P: -2.28, M/L: ±2.7, D/V: −8.5
mm from skull surface). Electrodes were implanted with a 7˚ angle to allow enough room to
attach the stimulating cords on both sides. Electrodes were secured to the skull using dental
cement and three screws. Animals were closely observed during the immediate post-operative
interval. Buprenorphine 0.05 mg/kg was administered subcutaneously to alleviate pain and
suffering pre and postoperatively. Animals showing any signs of infection (i.e. swelling, or dis-
charge at scalp incision site) or manifestations of postoperative neurological damage (i.e. limp-
ing, posturing, or inability to move freely) due to electrode implantation were euthanized for
humane purposes.
Mania-induction protocol
Following one hour habituation, bilateral lateral hypothalamic kindling was performed
using a 10 s long sequence of square bipolar pulses of 180 Hz frequency and 200 μs pulse
width, followed by 30 s of rest. Seven trains were applied, each consisting of 10 pairings
of 10 s duration stimulation pulses alternating with 30 s of rest, and 2 min of rest were
allowed between trains. Stimulation amplitude, i.e. electric potential difference between
the electrodes was 1 V at the beginning, and was increased by 1 V increments to 7 V for
the rest of stimulation trains. Kindling elicited typical manic-like behaviors as reported
previously [60,61].
Blood collection protocol
A total of 31 samples (50 μL each) were collected over 24 hours. Blood volume was automati-
cally replaced with an equal volume of heparinized saline after each sample. Total amount of
blood drawn throughout the 24 hour experiment was about 1.55 ml or 7.5% of total blood vol-
ume [circulating blood volume in laboratory rat 64 ml/kg or 21 ml in a rat weighing 300
g, drawing 1.55 ml 7.5%]. The stress caused by this degree of hypovolemia is considered
mild [77]. Blood was collected to a precooled micro tube then centrifuged (3000 g × 10 min at
4˚C). Collected serum was stored at—20˚C until analysis.
In order to confirm that the baseline corticosterone in the kindled animals is not different
from sham and control animals before and after kindling, we have performed blood sampling
in kindling experiment in two different ways. In one set of experiments, samples 1–23 were
collected at 60 min intervals; samples 24–29 were collected at 10 minute intervals during kin-
dling; followed by samples 30 and 31 collected at 30 min intervals after kindling. In the other
set of experiments, sample 1 was collected 50 min before kindling; samples 2–7 were collected
at 10 min intervals during kindling (or sham stimulation); samples 8–31 were collected at 60
min intervals. We have verified that increased sampling frequency during a short time–at 10
min intervals during 60 min, does not activate the HPA axis on its own. Occasionally, sam-
pling was temporarily discontinued due to difficulties, most often due to blood clothing or air
bubbles in the sampling tube, resulting in a loss of data points. However, sampling was contin-
ued according to the protocol, as soon as it was technically feasible. Immediately following the
last sample collection, animals were deeply anesthetized in a CO2 chamber and euthanized by
rapid decapitation.
HPA axis dynamics in LHK rat
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Serum corticosterone assay protocol
Serum samples were analyzed in duplicates using commercial ELISA kit (# ADI-901-097,
Enzo Life Science, NY, USA) according to manufacturer instruction. Inter-assay coefficient of
variance is 4.1%.
Mathematical modeling
Development of the stoichiometric network model of HPA axis activity in rodents.
The HPA axis is a complex master integrator of the neuronal and endocrine systems that regu-
lates various bodily processes under basal physiological conditions and stress [78–80]. It syn-
chronizes the actions of the hypothalamus, pituitary and adrenal glands by controlling the
plasma levels of corticosteroids secreted from the adrenal glands through a complex cascade of
reactions that are intertwined via positive and negative feedback loops (Fig 1). HPA axis hor-
mones exhibit complex daily rhythms with two principal periods, ultradian oscillations with a
period of 20 min– 2 hours and circadian oscillations with a period of about 24 hours [81–83].
Targeted experimental studies have for many years been unsuccessful in identifying the ana-
tomical origin of ultradian rhythms [84]. However, recent work suggests that an additional
level of glucocorticoid autoregulation may exist within the adrenal glands [85], further
strengthening the view that birhythmic oscillatory changes in blood glucocorticoid levels
reflect the integrated activity of pulsatile hypothalamic forcing on an endogenously rhythmic
pituitary-adrenal system.
Based on these experimental findings reported in the literature and building further on our
models of HPA axis in humans [64,65,69–71], we developed here a stoichiometric network
Fig 1. Self-regulation of HPA axis activity. A. Concise schematic presentation of biochemical pathways considered in the reaction
model of HPA axis dynamics given in Table 1. The reaction model includes CRH, ACTH, ALDO and CORT that comprise the backbone of
the HPA axis in humans, and CTS the leading glucocorticoid in rodents. Complex interactions between the considered species give rise to
positive (+) and negative (-) feedback loops through which the concentration of all reactive species is finely controlled. B. Cholesterol and
products of adrenal steroidogenesis included in the reaction model in Table 1 are shown in black. Intermediates that are presently not
included in the reaction model are shown in blue. Steroidogenic enzymes that catalyze specific steps in cholesterol conversion to active
steroid hormones are indicated in red.
https://doi.org/10.1371/journal.pone.0177551.g001
HPA axis dynamics in LHK rat
PLOS ONE | https://doi.org/10.1371/journal.pone.0177551 May 18, 2017 5 / 21
model that succinctly describes complex neurochemical transformations that constitute the
HPA axis in rodents (Table 1). Of note, steps (R1)-(R25) in Table 1 are not elementary bio-
chemical reactions but rather summarized outcomes of complex biological pathways that are
concisely presented in the form of stoichiometric relations (see S1 Appendix for detailed
description). Consequently, rate constants (ki) in Table 1 are not experimentally measured
kinetic rate constants of any elementary biochemical reaction, but rather values derived by sys-
tematic and stringent theoretical analysis of the network of interactions presented in Table 1
(described in the paragraph below). This representation allows us to describe the overall rates
Table 1. Stoichiometric network model describing self-regulation of HPA axis hormones in rats.*
Stoichiometric relation Rate constant No.
! CHOL k1 = 5.5200×10−5 M min-1 (R1)
! CRH k2×D; k2 = 2.2875×10−8 M min-1 (R2)
! ALDO k3 = 7.3080×10−11 M min-1 (R3)
CRH ! ACTH k4 = 1.0811×104 min-1 (R4)
ACTH + CHOL ! PNN k5 = 3.4240×107 M-1min-1 (R5)
PNN ! PGS k6 = 7.7371 min-1 (R6)
PGS ! DCTS k7 = 3.8686 min-1 (R7)
DCTS ! CTS k8 = 1.1606×10−2 min-1 (R8)
CTS ! ALDO k9 = 1.2000×10−3 min-1 (R9)
PGS ! HPGS k10 = 1.0000×10−5 min-1 (R10)
PNN ! HPNN k11 = 6.1900×10−2 min-1 (R11)
HPNN ! HPGS k12 = 1.2380×10−2 min-1 (R12)
HPGS ! CORT k13 = 6.1900×10−2 min-1 (R13)
DCTS + 2CTS ! 3CTS k14 = 1.5120×1012 M-2min-1 (R14)
ALDO + 2CTS ! CTS k15 = 8.4600×1010 M-2min-1 (R15)
CRH + CTS ! k16 = 3.6000×1010 M-1min-1 (R16)
ACTH + CTS ! k17 = 3.0000×109 M-1min-1 (R17)
CHOL ! k18 = 1.6200×10−1 min-1 (R18)
CRH ! k19 = 6.6000×10−4 min-1 (R19)
ACTH ! k20 = 6.4200×102 min-1 (R20)
CTS ! k21 = 7.3800×10−2 min-1 (R21)
ALDO ! k22 = 1.6200×10−1 min-1 (R22)
CORT ! k23 = 1.6200×10−1 min-1 (R23)
PNN ! k24 = 1.2840×10−2 min-1 (R24)
PGS ! k25 = 1.0000×10−5 min-1 (R25)
* Relations (R1)-(R25) concisely represent complex biochemical pathways that constitute the HPA axis. Relations (R1)-(R3) represent the biosynthesis of
cholesterol (CHOL), corticotrophin releasing hormone/corticotrophin releasing factor (CRH) and aldosterone (ALDO), respectively. Relation (R4) describes
the CRH stimulated adrenocorticotrophic hormone (ACTH) production from the pituitary. Relations (R5)-(R13) concisely summarize the multifaceted
synthesis of steroid hormones in the adrenal cortex and their secretion into the global circulation, which starts by ACTH-mediated conversion of cholesterol
to pregnenolone (PNN), followed by conversion to progesterone (PGS), deoxycorticosterone (DCTS), 17α-Hydroxypregnenolone (HPNN), 17α-
Hydroxyprogesterone (HPGS). Relations (R14) and (R15) describe the positive and negative feedback actions of corticosterone, respectively, which is
mediated via hippocampal glucocorticoid receptors (GR) and mineralocorticoid receptors (MR). The positive feedback actions of corticosterone are
described in the form of cubic autocatalysis (R14), whereas the negative feedback actions of corticosterone (CTS) are described in the form of quadratic
autoinhibition with respect to corticosterone (R15). GR and MR concentrations are implicitly included in the kinetic rate constants, and do not appear as
independent reactive species in the model. Relations (R16) and (R17) describe the negative feedback action of corticosterone on the hypothalamus and
pituitary, respectively, to suppress CRH and ACTH production. Relations (R18)-(R25) describe the removal (by bioconversion and/or elimination) of CHOL,
CRH, ACTH, CTS, ALDO, CORT, PNN and PGS from the circulation. Products of bioconversion do not participate as reactants in any reaction and are
therefore not specified in the model.
https://doi.org/10.1371/journal.pone.0177551.t001
HPA axis dynamics in LHK rat
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of transformation of the neurochemicals included in the model by a set of ordinary differential
equations (ODEs) derived based on the law of mass action (S1 Table).
In order to derive rate constants (ki) for the relations in Table 1, we closely rely on our
work that underlies the development of a stoichiometric network model of HPA axis in
humans [69–71]. This is possible because the biological pathways that underlie the HPA axis
in humans and in rodents and the stoichiometric network of interactions that represents them
are structurally similar, i.e. the number of variables in the system and the way that these vari-
ables are connected to each other are analogous. However, the actual values of rate constants
(ki) that define the HPA axis dynamics are not the same in rodents and humans because of
interspecies differences and because the leading corticosteroid in rodents and humans are not
the same. Derivation of the instability conditions for the 5-dimensional stoichiometric net-
work core model by SNA [72–75] is described in detail in [69,70]. By knowing the instability
conditions, the actual concentrations of HPA axis hormones in the peripheral circulation in
rats (S2 Table) and the frequency of ultradian oscillations, we could now identify the narrow
range of kinetic parameters, i.e. determine the values of rate constants ki that are specific for
the HPA axis model in rodents, for which the model in Table 1 yields ultradian oscillations in
HPA axis hormone levels that occur in physiologically relevant concentration ranges (S2
Table) and with a realistic ultradian frequency.
Numerical simulations. Numerical simulations were performed using MATLAB ode15s
solver based on the Gear algorithm for integration of stiff differential equations [86]. Absolute
and relative tolerance error values were 3×10-20 and 1×10-14, respectively. Integration was per-
formed with stricter tolerances in order to minimize potential numerical artefacts, but the
same dynamical behavior was observed using values 1×10−9 and 3×10−6 for absolute and rela-
tive tolerance, respectively.
Mathematical modeling of HPA axis activity under normal physiology (control condi-
tions). The reaction model and kinetic rate constants (ki, i = 1–25) used in the numerical
simulation of HPA axis dynamics under control conditions are shown in Table 1. Differential
equations describing changes in HPA axis hormone concentrations were derived from the bio-
chemical relations given in Table 1 in accordance with the law of mass action (S1 Table). The
circadian rhythm was modeled as an asymmetric forcing function, D, with a period of 24
hours [69,87,88]:
D ¼ d1   0:079145093 d2 þ fð0:064 sinð2pðt   840Þ=1440Þ
þ0:12 abs½sinðpðt   840Þ=1440g  d2
where parameters d1 = 0.2662 and d2 = 2.5, and 1440 in the denominator of the trigono-
metric function argument represents the number of minutes in one day, i.e. in one 24
hours period. The circadian rhythm function D is coupled through the CRH production
step (R2), and transforms the kinetic rate constant k2 into a periodic function k2 × D. Ini-
tial concentrations for integration of the underlying set of ordinary differential equations
(ODEs) were the same in all numerical simulations: [ACTH]0 = 8.00×10−13 M, [ALDO]0 =
1.50×10−9 M, [CHOL]0 = 3.40 ×10−4 M, [CTS]0 = 4.00×10−8 M, [CRH]0 = 1.00×10−12 M,
[CORT]0 = 1.50×10−9 M, [DCTS]0 = 4.00×10−9 M, [HPNN]0 = 1.00×10−10 M, [HPGS]0 =
4.00×10−8 M, [PNN]0 = 1.00×10−10 M, [PGS]0 = 4.00×10−8 M.
Mathematical modeling under sham conditions. In order to account for the increased
HPA axis activity under sham conditions, the rate of step (R2) describing CRH production
was increased by multiplying the rate constant k2, i.e. the value given in Table 1, by 1.1765.
HPA axis dynamics in LHK rat
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Mathematical modeling under acute mania-induction conditions. To model the tem-
poral evolution of corticosterone under LHK, kinetic parameters used for modeling sham con-
ditions were applied. Based on the classical in vitro study by Bradbury et al. who showed that
electrical stimulation of hypothalamus causes a frequency dependent CRH output [89], we
modeled the effects of electric stimuli applied in the in vivo experiments as acute perturbations
with CRH. In order to simulate acute perturbations with CRH, numerical integration of the
set of ODEs (S1 Table) was stopped at a specified time point, and new initial conditions for the
subsequent integration were defined. For the new initial conditions, CRH concentration was
increased for an indicated amount, whereas the concentrations of all other species retained the
values that they have attained before the numerical integration was stopped [64,71,90]. This
procedure has been repeated every 40 s during 50 min to mimic an actual LHK sequence. The
amount of CRH used to mimic LHK in numerical simulations, [CRH] = 5×10−8 M, is the
value that is determined to give rise to corticosterone levels that best agree with experimentally
measured values under LHK.
Results
LHK induces a sharp transient increase in serum corticosterone
concentration
Experimentally measured changes in corticosterone levels for one representative animal in
each group: control, sham and kindled, are shown in Fig 2. Concurrent data sets, consisting of
discrete measurements for all animals in a group, are shown in Fig 3 (symbols). One-way
ANOVA analysis revealed that overall serum corticosterone concentration increased signifi-
cantly during LHK (158 ± 16) and sham (128 ± 6), as compared to the control group (72 ± 3)
respectively [mean ± s.e.m., ng/mL; F2,53 = 14.5, p< 0.001]. However, this effect is transient
and disperses quickly after kindling is discontinued (Fig 2).
It is important to underline here that increased blood sampling frequency (10 min vs 60
min) does not seem to have any significant effect on the observed potentiation of HPA axis
activity, as evident from Fig 3A (bottom panel, green dots), where this effect was assessed.
In this experiment the sampling was increased to one sample per 10 min during 50 min
(around 22 hours) without performing LHK, but obvious HPA axis activation was not
observed.
Fig 2. Experimentally measured temporal changes in corticosterone concentrations during LHK.
Experimentally measured changes in corticosterone concentrations in individual animals: control (open circle,
blue), sham (rectangle, black) and kindled (solid circle, red). The shaded region indicates the interval during
which LHK was applied.
https://doi.org/10.1371/journal.pone.0177551.g002
HPA axis dynamics in LHK rat
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Mathematical modeling of HPA axis dynamics under normal physiology
and under LHK
Numerical integration of ODEs (S1 Table) yields the temporal evolution of daily corticoste-
rone levels under normal physiology (Fig 3A, top; solid line). Here we show data for
Fig 3. Experimental and numerically simulated temporal changes in corticosterone concentrations during
LHK. A. Temporal changes in corticosterone concentration under control (top), sham (middle) and LHK (bottom)
conditions measured experimentally; n = 3–4 animals/group (symbols) and as predicted by mathematical modeling
(solid lines). The data presented with blue circles, black squares and red dots are the same as corresponding data
shown in Fig 2. B. Time traces showing the dynamic behavior just before, under and shortly after LHK, from 20:00–
23:00 h. Top: Numerically simulated CRH dynamics before, during and shortly after LHK. Individual CRH pulses
during an LHK kindling sequence that starts at 21:12 o’clock and lasts until 22:02 o’clock, are visible as vertical
lines, representing an abrupt change in CRH concentration induced by a 10 s long sequence of square bipolar
pulses of 180 Hz frequency and 200 μs pulse width, followed by 30 s of rest, which was modelled in numerical
simulation as an instantaneous perturbation applied every 40 s during 50 min. The intensity of a single CRH pulse
was 5×10−8 M. Bottom: Corresponding changes in corticosterone concentrations. This time trace is the same as
shown at the bottom (A), except that a shorter time span, from 20:00–23:00 o’clock, is presented here. The first
oscillation is the last oscillation before LHK, visible at the bottom of (A). LHK starts at 21:12 o’clock and lasts until
22:02 o’clock. After LHK is discontinued, the HPA axis activity is quickly being restored, as evident from the time
trace shown at the bottom of (A).
https://doi.org/10.1371/journal.pone.0177551.g003
HPA axis dynamics in LHK rat
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corticosterone because we have experimental measurements only for corticosterone, but the
model predicts the evolution of daily levels of all neurochemicals considered in the model and
the agreement between model predictions and experimentally measured HPA axis hormone
concentrations is very good (S2 Table).
We show the results of numerical simulation for one set of control parameters in each
group (Fig 3A–3C, solid lines) for the following reason. It is well-established that diurnal and
ultradian HPA axis dynamics under normal physiology is reasonably stable for an individual
but can significantly differ between individuals [91]. Our experimental data do not have suffi-
cient temporal resolution to characterize ultradian oscillations in an individual animal. By pre-
senting the data indiscriminately, taking into account data from all animals in the same group,
we could optimize the model and derive one set of control parameters that best agrees with all
data from the same group. In reality, one should actually use slightly different parameter values
for each animal in order to account for individual differences in circadian and ultradian rhyth-
micity. However, since our aim here is not to mimic the HPA axis dynamics in an individual
animal, but rather to model a general response, this approach is fully justified.
Experimental analysis of temporal changes in corticosterone concentration under control,
sham and LHK conditions shows that average corticosterone levels and the amplitude of ultra-
dian corticosterone oscillations increase under acute induction of manic-like states by LHK
(Figs 2 and 3). It also shows that these effects are transient, and disperse quickly after kindling
is being discontinued (Figs 2 and 3, red dots). Mathematical modeling can veritably imitate
these experimental observations and shows that average corticosterone levels, the amplitude
and frequency of ultradian corticosterone oscillations all increase under sham conditions and
under acute mania-induction (Fig 3, solid line). In addition, mathematical modeling also
showed that these effects are transient when the kindling time is short (here 50 min), and dis-
perse quickly after kindling is discontinued (Fig 3A, bottom; magnified in Fig 3B), in agree-
ment with experimental observations (Fig 2).
Changes in HPA axis dynamics induced by LHK of different intensity and
duration predicted by mathematical modeling
The mathematical model predicts that with continuous kindling the HPA axis will enter a new
dynamical regime and will maintain large-amplitude ultradian oscillations as long as kindling
persists (Fig 4A). According to the mathematical model predictions, LHK of increasing inten-
sity increases the amplitude and the frequency of ultradian corticosterone oscillations (Fig 4B–
4D). This increase in ultradian oscillation amplitude is accompanied by further deviation from
the normal oscillatory pattern into complete loss of circadian oscillations (Fig 4B, bottom
panel). While further studies are needed to characterize the effect of progressively longer
mania-induction durations on oscillatory behavior of serum corticosterone and test the pre-
dictive validity of the model, the results in Fig 4B clearly demonstrate HPA axis allostasis, i.e.
the process of achieving stability by changing the underlying dynamics–as the allostatic load
increases with increasing LHK intensity, the HPA axis alters its dynamics accordingly (Fig 4B–
4D). This adaptation lasts only as long as the HPA axis is under the influence of LHK and nor-
mal dynamics is restored after LHK is discontinued (Fig 4A).
Discussion
The results of this study show that LHK causes robust increase in serum corticosterone, a surro-
gate marker of HPA axis hyperactivity, which is transient in nature and lasts only as long as LHK
is applied (Figs 2 and 3). This effect could be emulated by the mathematical model in Table 1
as a consequence of an increased CRH output caused by LHK (Fig 3B). This novel finding
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strengthens the notion of an important role of CRH in the pathophysiology of mood disorders
[92], and is in agreement with clinical data on hypothalamic hamartoma–patients with this non-
neoplastic tumor present with mood symptoms [93] and also elevation in CRH concentration
[94]. However, it might seem contradictory to other data of emerging manic symptoms in pa-
tients receiving corticosteroid treatment for medical conditions (reviewed in [95]). It is possible
to speculate that exogenous corticosteroids also have indirect effect on the hypothalamic neuro-
nal firing. Indeed, Chu et al. [96] showed that exogenous CRH decreases hypothalamic neuronal
firing through reducing T-type Ca2+ channel activity. In this scenario, treatment with corticoste-
roids exerts a negative feedback at the level of the hypothalamus suppressing CRH secretion.
Low CRH levels could release the suppression of hypothalamic neurons and cause an increase in
neuronal firing and excitability. Under stress or in vulnerable individuals, this enhanced excit-
ability could manifest as manic-like symptoms.
Interestingly, our experimental studies presented here show that HPA axis dynamics in
the sham group showed slight “potentiation” as compared to the controls (Fig 2). This
observation is in agreement with clinical data showing persistently abnormal HPA axis
activity in euthymic bipolar patients [16,17,29,31–33,97,98]. Based on the fact that sham
animals only had an electrode implanted in the LH bilaterally, it is possible that the surgical
intervention, anesthesia [99] and/or stress due to the mere presence of electrodes could be
instrumental in changing neuronal excitability, thus affecting serum corticosterone. Further
Fig 4. Effect of LHK duration and intensity on HPA axis activity. A. Changes in HPA axis dynamics induced by LHK of different
duration: 50 min, 3 hours, 5 hours, 10 hours and 72 hours (from top to bottom) but the same intensity of a single CRH pulse, 5×10−8 M. B.
Changes in HPA axis dynamics induced by LHK of the same duration (72 hours) but different intensity. The intensity of a single CRH pulse
during LHK was: 2×10−8 M (top), 2×10−7 M (middle) and 1×10−6 M (bottom). C. The amplitude of ultradian corticosterone oscillations
increases as the intensity of LHK is being increased. Solid circles indicate the highest and the lowest value of the ultradian corticosterone
oscillation with the largest amplitude. Open circles indicate the corresponding values under sham conditions, without LHK. D. The
frequency of ultradian oscillations increases as the intensity of LHK is being increased. The open circle at the origin indicates the frequency
of ultradian oscillations under sham conditions, without LHK.
https://doi.org/10.1371/journal.pone.0177551.g004
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studies are needed to assess these contributions. However mathematical modeling showed
that this effect can be mimicked when CRH production is increased via the rate constant k2,
showing that good agreement with measured corticosterone in this group is achieved when
the stress factor in the model is increased.
It is important to note that the measured corticosterone concentrations show variability
between individual animals in the same group (Fig 3A, symbols). This variability could be
explained by the well-established fact that under normal physiological conditions, diurnal and
ultradian HPA axis dynamics are stable in a given individual but can significantly differ
between individuals [91]. Merging the data within the same group, as was done in this study
(Fig 3A), prevents us from detecting individual variations in the estimated model parameters,
i.e. rate constants, but it ensures a good robustness of the values obtained for each group.
Because of biological restrictions on blood sampling frequency, we do not have sufficient tem-
poral resolution to characterize ultradian oscillations in individual animals, but Fig 3A clearly
shows that the apparent scatter of experimental data points is due to diurnal and ultradian
oscillations in their level, rather than due to experimental measurement errors. Thus, we con-
clude that our mathematical model predicts the complex daily dynamics of HPA axis activity
under normal physiological conditions from different aspects. First, the model predicted hor-
mone levels that are, in most cases, in quantitative agreement with published concentrations of
HPA axis hormones in rodent models (S2 Table); second, the period of ultradian oscillations is
also in good agreement with previously published data acquired with high temporal resolution
[100]; third, the model predicts amplitude-dependent increase in CRH values with stimulation
which is concordant, despite with different concentrations, with another report showing fre-
quency-dependent CRH concentration with hypothalamic stimulation [89]. In our model, we
have chosen the CRH value 5×10−8 M based on our measured corticosterone data–so that the
level of corticosterone that is “generated” in numerical simulations is of the same order of
magnitude as what was experimentally measured. This assumption did not negatively impact
the ability of the model to predict HPA axis hormones, and the predicted value is in accor-
dance with in vitro experimental studies showing that 1.5×10−8 M– 2.50×10−7 M CRH modu-
lates voltage-gated ion currents important for the generation of action potentials in CA1 and
CA3 pyramidal neurons of rat/mouse hippocampal brain slices [101,102]. We can also com-
pare the model-predicted value with CRH amounts used in a CRH stimulation test, where a
CRH dose of 1 μg/kg (humans) or 10 μg/kg (rats) is typically administered as a single intrave-
nous (i.v.) injection, yielding a CRH concentration of 3×10−9 M< [CRH] < 3×10−8 M in the
peripheral blood circulation (calculated for 5.25 l of blood in an average male of 70 kg; or for
70 ml/kg for rats). This level of change in CRH concentration is typically well tolerated, with
the most common side effects being transient facial flushing and rare dyspnea or hypotension
[103]; and was shown to induce a 3-fold increase in corticosterone concentration [104]. In
comparison with these values, an increase in CRH levels of 5×10−8 M in an LHK-induced
manic-like episode, as was predicted by the model, seems not to be entirely unrealistic, but
calls for testing in future studies.
Our work is also of more general bearing. In this study, we used mathematical modeling to
explore only few aspects of the complex HPA axis dynamics. However, the reaction model devel-
oped here (Table 1) has the capacity to probe other clinically relevant changes, which are beyond
the access of previously developed mathematical models of HPA axis activity [66,100,105,106].
For example, the effects of steroidogenesis enzymes activity on HPA axis dynamics shown by
several groups to be affected in bipolar patients [36] could be easily probed by modifying the rate
constant for corresponding reaction steps in the reaction model, thereby mimicking the effects
of enzymatic activity on the HPA axis dynamics. Similarly, the effect of cholesterol, the only
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precursor of steroid hormones, and of all peptide and steroid hormones that are variables in the
reaction model can be systematically examined.
Having said this, we also need to caution about limitations of mathematical modeling of
dynamical biochemical systems, in general, and the model presented here, in particular. The
HPA axis is an inherently complex dynamical system. It is made up of a large number of differ-
ent constituents, molecules and cells, which interact to build a spatially and temporally inter-
twined dynamical network. In this intricate network, molecules produced by one type of cells
are distributed across tissue/organ/the whole organism to act on other types of cells, stimulating
them to produce other molecules that exert feedback and/or feedforward actions and thus regu-
late the rates at which biochemical transformations occur in pathways that comprise the HPA
axis. As a consequence, the HPA axis acquires a collective feature that is not characteristic of
the individual pathways, such as the capacity to self-organize, i.e. to self-adjust its essential vari-
ables in response to signals from within and from the surroundings in order to maintain within
acceptable limits its own dynamical structure. When building mathematical models, we substi-
tute this vast complexity by a tractable set of mathematical equations that can imitate these intri-
cate dynamical features. Hence, all mathematical models of complex biochemical systems are
an oversimplified representation of the real system and are therefore limited. This is also true
for the mathematical model developed here (Table 1), where the effect of a number of important
molecules known to affect HPA axis activity, most notably arginine-vasopressin (AVP), angio-
tensin II (ATII), epinephrine (adrenalin), dopamine, serotonin etc., is not considered.
In addition, CRH generation was modeled here using a continuous function (R2), with a
rate that varies with the circadian rhythm represented by the periodic function D, whereas in
reality CRH is not continuously released but is rather discharged in discrete pulses several
dozen of times per day. While continuous deterministic models of chemical kinetics may give
solutions that differ from the ones obtained by models that take into account inherent fluctua-
tions in the concentration of reactants, this difference becomes important under conditions
that involve a low number of molecules (e.g.< 104) or in the proximity of bifurcation points.
[107,108] Under other conditions the errors caused by assuming a continuous range of possi-
ble concentrations are usually very small, and the continuous and discrete approach yield the
same macroscopic steady state solution [107,108]. Hence, continuous inflow of CRH, while
clearly a simplification, is not unfounded as long as the average CRH concentration in a pulsa-
tile CRH regime is the same as in the continuous flow regime.
Another important limitation of our model is that many complex processes were combined
into one reaction step, such as the reaction steps (R1)-(R25) in Table 1. This conciseness, while
a necessary first step towards determination of the overall behavior of the HPA axis, needs to
be disentangled if more detailed questions about the role of specific processes, such as the role
of gene transcription and translation, protein synthesis, post-translational modification, intra-
cellular trafficking etc. are to be examined.
Finally, we underline that all reactive species were treated in our model as if they were spa-
tially homogenous, which is clearly not the case. Once again, this simplification is a justifiable
first approximation for the current purposes, where we examine the effect of LHK on the over-
all dynamics of the HPA axis, but spatial discretization needs to be included if specific ques-
tions about the role of different compartments, e.g. the contribution of different brain regions,
want to be addressed.
Having in mind these limitations, the model of HPA axis in rats that is developed here
(Table 1), as well as mathematical models of any dynamical biochemical system, should always
be regarded as a work in progress and mathematical modeling should be regarded as an itera-
tive process that alternates between laboratory measurements and numerical simulations.
Mathematical models are always built based on our current understanding of the problem and
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on existing experimental data. However, new technologies with improved detection sensitivity
continuously provide important new insights. When new experimental facts are obtained, one
needs to re-examine whether the existing mathematical model can or cannot account for these
new observations and, based on the outcome, decide whether to refine them or to reject them.
Along the same lines, we would also like to point out that while in this study we tested our
mathematical model on the experimentally established LHK-induced CRH surfeit [89], further
studies are needed to investigate the hypothesis that HPA over-activity in LHK may be driven
by an excess of the AVP hormone [15,109]. There is abundant evidence demonstrating the co-
expression of CRH and AVP in hypothalamic neurons [110], possibly to potentiate the effects
of CRH on pituitary corticotrophes and to coordinate the activation of the HPA axis during
chronic stress by driving the release of ACTH [111]. AVP modulates complex social behavior,
emotional states, aggression with sensitivity to psychosocial stress [112]. Furthermore, CSF
AVP was increased in manic patients compared with depressed, schizophrenic and healthy con-
trols [113] and in bipolar patients taking lithium compared to healthy controls [114], and an
association was recently found between the TT genotype of rs28536160 polymorphism of the
AVPR1b gene and bipolar disorder with psychotic features and also with genotype CC of
rs1293651 polymorphism of CRHR1 gene [115]. At this stage, we have included steroid hor-
mones in our mathematical model and not included AVP in order to keep the model concise
and tractable, yet sufficiently resourceful to recapitulate the most important features of the com-
plex real system that we are modeling. This first approximation is justifiable on factual basis–it
is well established that CRH is the primary and most potent activator of the HPA axis and that
AVP acts primarily as a modifier of its activity, rather than its main driver [116–118]. In addi-
tion, there are, to our best knowledge, no experimental data on the daily dynamics of AVP that
are acquired with such a high temporal resolution to enable us to distinguish the contribution
of CRH from the contribution of AVP and refine our model in accordance with these data.
There are also no primary data on the effect of LHK on AVP. Thus, future studies measuring
with high temporal resolution AVP and other hormones in LHK are urgently needed.
Similarly, in this study, we used a wide range of stimulation intensity (1V – 7V) and we
did not study the effect of a narrow range of stimulation intensity on HPA axis dynamics.
We have previously shown that LHK of wide stimulation intensity range (1V – 7V) and the
limited stimulation intensity range (1V – 2V) reliably induces manic-like behaviors in male
and female rats [60,61]. Male rats seemed to exhibit manic-like behaviors at higher stimula-
tion threshold compared to females, so we adopted in this study the wide range stimulation
intensity scale to achieve the behavioral phenotype. Future studies are needed to character-
ize the relationship between specific stimulation parameters and individually induced
manic-like behaviors.
Concluding remarks
In this study, we have found sharp increase in serum corticosterone during LHK (Fig 2, red)
and developed a mathematical model of HPA axis in rats (Table 1) that can emulate these
changes by numerical simulations (Fig 3). The observed increase in corticosterone levels is in
agreement with a large body of literature showing HPA axis hyperactivity during manic epi-
sode. Mathematical modeling predicts that excessive LHK would drive the HPA axis dynamics
away from its regular pulsatile oscillation pattern, eventually causing a loss of circadian rhyth-
micity (Fig 4) and, hence, loss of an important dynamic self-regulation mechanism. Due to
lack of experimental evidence, it is presently not possible to assess the accuracy of these predic-
tions, but we demonstrate here how mathematical modeling can be used to provide informa-
tion for states for which experimental data is scarce.
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Our experimental results show for the first time that LHK causes an increase in serum corti-
costerone concentration in the rat that is reminiscent of mania-associated HPA axis hyperac-
tivity in humans. Further studies are needed to establish whether a “potentiated” HPA axis
could serve as a vulnerability marker for predicting the onset/duration of future manic epi-
sodes, but the encompassing interdisciplinary approach presented here, by rigorously con-
trolled animal experiments, numerical simulations and dynamical systems theory, represents a
significant step forward towards the development of quantitative tools to investigate self-regu-
lation of HPA axis activity in order to understand how the inherently complex neurochemical
transformations, through which a coherent HPA axis activity is maintained under normal
physiology, are disrupted in manic-like states.
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